{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-08T17:23:52.103672+00:00","published_at":"2026-10-08T04:46:15.670059+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v1","events":[{"event_id":"alpha:event:ceo_changed:xhvbun","event_type":"CEO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","alpha:person:carmine-stengone"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:df370dd3cb6f6d8d23f4c42b8f8f041a06f7150980b5566d846b0c787b314feb"],"summary":"Carmine N. Stengone executive of Contineum Therapeutics, Inc., effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:15h9o42","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","alpha:person:olivia-ware"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Olivia Ware seat on Contineum Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:1ryfcz1","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","alpha:person:sarah-boyce"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Sarah Boyce seat on Contineum Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:torwue","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","alpha:person:troy-ignelzi-2"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Troy Ignelzi seat on Contineum Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:1byeyac","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:committee:contineum-therapeutics-inc:compensation-nominating-and-governance","alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Compensation; Nominating and Governance committee of Contineum Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:78w9qp","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:committee:contineum-therapeutics-inc:compensation-nominating-and-governance","alpha:person:olivia-ware"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Olivia Ware member of Compensation; Nominating and Governance, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:1x7ihae","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:committee:contineum-therapeutics-inc:nominating-and-governance-chair","alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Nominating and Governance · Chair committee of Contineum Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:1eosrl6","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-08T04:46:15.670059+00:00","subject_ids":["alpha:committee:contineum-therapeutics-inc:nominating-and-governance-chair","alpha:person:sarah-boyce"],"caused_claim_ids":["alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c"],"summary":"Sarah Boyce member of Nominating and Governance · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5","subject_id":"alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:olivia-ware","object_label":"Olivia Ware","object_source_name_forms":[],"value":"Olivia Ware: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:olivia-ware","name":"Olivia Ware"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-08T04:46:15.670059+00:00","sources":[{"id":"alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Contineum Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:02.428+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-08T04:46:15.670059+00:00","reviewed_at":"2026-10-08T04:46:15.670059+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6","subject_id":"alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sarah-boyce","object_label":"Sarah Boyce","object_source_name_forms":[],"value":"Sarah Boyce: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sarah-boyce","name":"Sarah Boyce"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-08T04:46:15.670059+00:00","sources":[{"id":"alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Contineum Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:02.428+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-08T04:46:15.670059+00:00","reviewed_at":"2026-10-08T04:46:15.670059+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:7","subject_id":"alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:troy-ignelzi-2","object_label":"Troy Ignelzi","object_source_name_forms":[],"value":"Troy Ignelzi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:troy-ignelzi-2","name":"Troy Ignelzi"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-08T04:46:15.670059+00:00","sources":[{"id":"alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Contineum Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:02.428+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-08T04:46:15.670059+00:00","reviewed_at":"2026-10-08T04:46:15.670059+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:8","subject_id":"alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:carmine-stengone","object_label":"Carmine N. Stengone","object_source_name_forms":[],"value":"Carmine N. Stengone: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:carmine-stengone","name":"Carmine N. Stengone"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-08T04:46:15.670059+00:00","sources":[{"id":"alpha:projection-evidence:document:df370dd3cb6f6d8d23f4c42b8f8f041a06f7150980b5566d846b0c787b314feb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CTNM DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/ctnm-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:10:10.977958+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-08T04:46:15.670059+00:00","reviewed_at":"2026-10-08T04:46:15.670059+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Contineum Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:02.428+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:df370dd3cb6f6d8d23f4c42b8f8f041a06f7150980b5566d846b0c787b314feb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CTNM DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/ctnm-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:10:10.977958+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.824,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.827,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":15,"factual_claims":15,"claims_with_linked_evidence":15,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":8,"temporal_claims_with_valid_from":4,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-08T04:46:15.670059+00:00","observed_at":"2026-10-08T04:46:15.670059+00:00","reviewed_at":"2026-10-08T04:46:15.670059+00:00","verified_at":"2026-10-08T04:46:15.670059+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":15,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/contineum-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}